243 related articles for article (PubMed ID: 27867277)
21. Enhanced dissolution and oral bioavailability of valsartan solid dispersions prepared by a freeze-drying technique using hydrophilic polymers.
Xu WJ; Xie HJ; Cao QR; Shi LL; Cao Y; Zhu XY; Cui JH
Drug Deliv; 2016; 23(1):41-8. PubMed ID: 24735247
[TBL] [Abstract][Full Text] [Related]
22. Dissolution, bioavailability and ulcerogenic studies on piroxicam-nicotinamide solid dispersion formulations.
Verma MM; Kumar MT; Balasubramaniam J; Pandit JK
Boll Chim Farm; 2003 Apr; 142(3):119-24. PubMed ID: 12806831
[TBL] [Abstract][Full Text] [Related]
23. Preparation of osthole-polymer solid dispersions by hot-melt extrusion for dissolution and bioavailability enhancement.
Yun F; Kang A; Shan J; Zhao X; Bi X; Li J; Di L
Int J Pharm; 2014 Apr; 465(1-2):436-43. PubMed ID: 24576810
[TBL] [Abstract][Full Text] [Related]
24. Physicochemical characterization and dissolution study of solid dispersions of Lovastatin with polyethylene glycol 4000 and polyvinylpyrrolidone K30.
Patel RP; Patel MM
Pharm Dev Technol; 2007; 12(1):21-33. PubMed ID: 17484141
[TBL] [Abstract][Full Text] [Related]
25. Development of a tin oxide carrier with mesoporous structure for improving the dissolution rate and oral relative bioavailability of fenofibrate.
Bai A; Wu C; Liu X; Lv H; Xu X; Cao Y; Shang W; Hu L; Liu Y
Drug Des Devel Ther; 2018; 12():2129-2138. PubMed ID: 30022811
[TBL] [Abstract][Full Text] [Related]
26. Application of scCO
Yang R; Li Y; Li J; Liu C; Du P; Zhang T
Drug Dev Ind Pharm; 2018 Feb; 44(2):289-295. PubMed ID: 29082762
[TBL] [Abstract][Full Text] [Related]
27. Applying Supercritical Fluid Technology to Prepare Ibuprofen Solid Dispersions with Improved Oral Bioavailability.
Han F; Zhang W; Wang Y; Xi Z; Chen L; Li S; Xu L
Pharmaceutics; 2019 Feb; 11(2):. PubMed ID: 30717471
[TBL] [Abstract][Full Text] [Related]
28. Mesoporous carbon with spherical pores as a carrier for celecoxib with needle-like crystallinity: improve dissolution rate and bioavailability.
Zhu W; Zhao Q; Sun C; Zhang Z; Jiang T; Sun J; Li Y; Wang S
Mater Sci Eng C Mater Biol Appl; 2014 Jun; 39():13-20. PubMed ID: 24863191
[TBL] [Abstract][Full Text] [Related]
29. Physicochemical and pharmacokinetic characterization of amorphous solid dispersion of tranilast with enhanced solubility in gastric fluid and improved oral bioavailability.
Onoue S; Kojo Y; Aoki Y; Kawabata Y; Yamauchi Y; Yamada S
Drug Metab Pharmacokinet; 2012; 27(4):379-87. PubMed ID: 22240843
[TBL] [Abstract][Full Text] [Related]
30. Cefdinir Solid Dispersion Composed of Hydrophilic Polymers with Enhanced Solubility, Dissolution, and Bioavailability in Rats.
Cho HJ; Jee JP; Kang JY; Shin DY; Choi HG; Maeng HJ; Cho KH
Molecules; 2017 Feb; 22(2):. PubMed ID: 28208830
[TBL] [Abstract][Full Text] [Related]
31. In-Vitro Characterization and Oral Bioavailability of Organic Solvent-free Solid Dispersions Containing Telmisartan.
Cao Y; Shi LL; Cao QR; Yang M; Cui JH
Iran J Pharm Res; 2016; 15(2):385-94. PubMed ID: 27642309
[TBL] [Abstract][Full Text] [Related]
32. Development of a rebamipide solid dispersion system with improved dissolution and oral bioavailability.
Pradhan R; Tran TH; Choi JY; Choi IS; Choi HG; Yong CS; Kim JO
Arch Pharm Res; 2015 Apr; 38(4):522-33. PubMed ID: 24895145
[TBL] [Abstract][Full Text] [Related]
33. In vivo and in vitro evaluation of a solid dispersion system of gliclazide:PEG 6000.
Asyarie S; Rachmawati H
PDA J Pharm Sci Technol; 2007; 61(5):400-10. PubMed ID: 18047178
[TBL] [Abstract][Full Text] [Related]
34. Enhanced dissolution and oral bioavailability of tanshinone IIA base by solid dispersion system with low-molecular-weight chitosan.
Liu QY; Zhang ZH; Jin X; Jiang YR; Jia XB
J Pharm Pharmacol; 2013 Jun; 65(6):839-46. PubMed ID: 23647677
[TBL] [Abstract][Full Text] [Related]
35. A silica-supported solid dispersion of bifendate using supercritical carbon dioxide method with enhanced dissolution rate and oral bioavailability.
Cai C; Liu M; Li Y; Guo B; Chang H; Zhang X; Yang X; Zhang T
Drug Dev Ind Pharm; 2016; 42(3):412-7. PubMed ID: 26219343
[TBL] [Abstract][Full Text] [Related]
36. Clopidogrel Napadisilate Monohydrate Loaded Surface-Modified Solid Dispersion: Physicochemical Characterization and in Vivo Evaluation.
Kim YH; Kim DW; Kwon MS; Cho KH; Kim JO; Yong CS; Choi HG
Biol Pharm Bull; 2015; 38(7):1033-40. PubMed ID: 26133713
[TBL] [Abstract][Full Text] [Related]
37. Development of hot melt co-formulated antimalarial solid dispersion system in fixed dose form (ARLUMELT): Evaluating amorphous state and in vivo performance.
Fule R; Dhamecha D; Maniruzzaman M; Khale A; Amin P
Int J Pharm; 2015 Dec; 496(1):137-56. PubMed ID: 26471056
[TBL] [Abstract][Full Text] [Related]
38. Preparation and Characterization of Furosemide Solid Dispersion with Enhanced Solubility and Bioavailability.
Zhang F; Mao J; Tian G; Jiang H; Jin Q
AAPS PharmSciTech; 2022 Jan; 23(1):65. PubMed ID: 35102461
[TBL] [Abstract][Full Text] [Related]
39. An Approach to Enhance Dissolution Rate of Tamoxifen Citrate.
SreeHarsha N; Hiremath JG; Chilukuri S; Aitha RK; Al-Dhubiab BE; Venugopala KN; Alzahrani AM; Meravanige G
Biomed Res Int; 2019; 2019():2161348. PubMed ID: 30800663
[TBL] [Abstract][Full Text] [Related]
40. Amorphous solid dispersion of berberine with absorption enhancer demonstrates a remarkable hypoglycemic effect via improving its bioavailability.
Zhaojie M; Ming Z; Shengnan W; Xiaojia B; Hatch GM; Jingkai G; Li C
Int J Pharm; 2014 Jun; 467(1-2):50-9. PubMed ID: 24607213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
